Warren and Klobuchar Say They Can Lower Drug Prices Without Congress’ Help
Democratic presidential candidates also returned to now-familiar themes in debating the differences between "Medicare for All" and more incremental reforms.
Drugs
681-700 of 1,312 results
-
-
Sanders Targets Health Industry Profits. Are His Figures Right?
Calculations are complicated, but correct.
-
Team Trump Says Administration’s Action On Health Care ‘Is Working.’ Is It?
The impact of the Trump administration’s health policies is not as clear-cut as the president’s reelection campaign suggests.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
Family Doctors In Rural America Tackle Crisis Of Addiction And Pain
For rural physicians, the burden of responding to the opioid epidemic falls squarely on their already loaded shoulders. For one doctor in a small Wisconsin village, there was no question that she wanted to rise to the challenge.
-
Effort To Control Opioids In An ER Leaves Some Sickle Cell Patients In Pain
People with sickle cell disease aren't fueling the opioid crisis, research shows. Yet some ER doctors still treat patients seeking relief for agonizing sickle cell crises as potential addicts.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
Readers And Tweeters: More Than Two Sides To Every Story
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
-
Warren’s Argument That Millions Can’t Afford Their Rx Drugs Holds Up
‘Medication insecurity’ is a thing.
-
KHN’s ‘What The Health?’: ACA Still Under A Cloud After Court Ruling
A federal appeals court in New Orleans has agreed with a lower court that a key piece of the Affordable Care Act is unconstitutional. But it is sending the case back to the lower-court judge to decide how much of the rest of the law can stand. Also, Congress is leaving town after finishing work on a major spending bill that includes many changes to health policy. Margot Sanger-Katz of The New York Times, Kimberly Leonard of the Washington Examiner and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss this and more.
-
Border Fight: Trump’s Plan To Import Cheaper Drugs From Canada Faces Hurdles
The administration’s proposed rule to allow states to bring in prescription medications isn’t expected to provide immediate relief.
-
Listen: The Cost Of PrEP, The HIV Prevention Pill
KHN correspondent Shefali Luthra was among the guests on the podcast "Today, Explained" to talk about PrEP.
-
What Would Happen If The ACA Went Away?
The Affordable Care Act has been on the books for nearly a decade. Parts of it have become ingrained in our health system ― and in our everyday life. But this could change, depending on a long-awaited 5th Circuit Court of Appeals decision regarding the law’s constitutionality.
By Julie Rovner -
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
Watch: The House Approved H.R. 3, The Pelosi Drug Bill. What Does That Mean?
KHN's Emmarie Huetteman appeared on PBS NewsHour to discuss efforts on Capitol Hill to curb the cost of prescription drugs.
-
KHN’s ‘What The Health?’: Legislate-A-Palooza
The House passed legislation that would give federal workers 12 weeks of paid parental leave. The measure appears headed for passage in the Senate, and President Donald Trump has promised to sign the measure into law. Meanwhile, House and Senate lawmakers have a tentative deal on surprise medical bills, but don’t count on a compromise just yet. Joanne Kenen of Politico, Kimberly Leonard of the Washington Examiner and Emmarie Huetteman of Kaiser Health News join guest host Mary Agnes Carey of KHN to discuss this and more. And for “extra credit,” the panelists offer their favorite health stories of the week they think you should read, too.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
-
KHN’s ‘What The Health?’: We Spend HOW MUCH On Health Care?
The annual accounting of national health spending is out. And the 2018 health bill for the U.S. was $3.6 trillion, consuming nearly a fifth of the nation’s economy. Meanwhile, Congress is nearing the end of the year without having finished either its annual spending bills or several other high-priority health items. Kimberly Leonard of the Washington Examiner, Joanne Kenen of Politico and Mary Agnes Carey of Kaiser Health News join KHN’s Julie Rovner to discuss this and more. Also, Rovner interviews KHN’s Markian Hawryluk about the latest KHN-NPR “Bill of the Month.”
-
Pharma’s Take On The Pelosi Drug-Pricing Bill: Fair Warning Or Fearmongering?
The pharmaceutical industry’s argument that capping drug prices would compromise drug innovation stands “on very shaky ground.”